Author:
Alqurshi Abdulmalik,Chan K. L. Andrew.,Royall Paul G.
Publisher
Springer Science and Business Media LLC
Reference80 articles.
1. Leucuta, S. E. Selecting oral bioavailability enhancing formulations during drug discovery and development. Expert Opin Drug Discov. 9, 139–50 (2014).
2. Flynn, G. L., Yalkowsk, S. H. & Roseman, T. J. Mass-Transport Phenomena and Models - Theoretical Concepts. J. Pharm. Sci. 63, 479–510 (1974).
3. Pouton, C. W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29, 278–87 (2006).
4. Patil, H., Tiwari, R.V. & Repka, M.A. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 1–23 (2015).
5. Chowdary, K. P. R. & Kumar, A. P. Recent research on formulation development of BCS class II drugs - a review. Int. Res. J. Pharm. Appl. Sci. 3, 173–181 (2013).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献